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Abstract
Objective—To examine the relationship between maternal hemoglobin (Hb) concentration and 
the risk of anemia in infancy.
Study design—This analysis included 17,193 women who entered the trial when they were 20 
years of age or older, no more than 20 weeks of gestation, had mild or no anemia, and delivered 
singleton live births. Maternal Hb concentrations were measured in the first trimester and during 
24-28 weeks of gestation; infant Hb concentrations were measured at 5-7 months and 11-13 
months of life. The associations between maternal Hb concentrations and infant Hb concentrations 
were examined.
Results—Maternal Hb concentrations measured during 24-28 weeks of gestation, but not in the 
first trimester, were correlated with infant Hb concentrations measured at either of the two post-
partum periods. The risk of infant anemia at 5-7 months increased when maternal Hb 
concentration was ≤109 g/L during 24-28 weeks of gestation ([AOR: 1.95, 95% CI: 1.59-2.40] and 
11-13 months [AOR: 1.72, 95% CI: 1.36-2.18]); whereas the risk of anemia during 5-7 months as 
well as 11-13 months in infancy decreased when maternal Hb level at 24-28 weeks of gestation 
was 120-129 g/L (AOR for 5-7 months: 0.74, 95% CI: 0.64-0.85; AOR for 11-13 months: 0.72, 
95% CI: 0.61-0.85) or ≥130 g/L (AOR for 5-7 months: 0.75, 95% CI: 0.63-0.90; AOR for 11-13 
months: 0.89, 95% CI: 0.73-1.08).
Correspondence: Aiguo Ren, Institute of Reproductive and Child Health, Peking University Health Science Center, 38 College Rd, 
Haidian District, Beijing 100191, China, renag@bjmu.edu.cn, Lei Jin, Institute of Reproductive and Child Health, Peking University 
Health Science Center, 38 College Rd, Haidian District, Beijing 100191, China, jinlei@bjmu.edu.cn. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
The authors declare no conflicts of interest.
Trial registration Clinicaltrials.gov: NCT00133744
HHS Public Access
Author manuscript
J Pediatr. Author manuscript; available in PMC 2017 August 01.
Published in final edited form as:
J Pediatr. 2016 August ; 175: 106–110.e2. doi:10.1016/j.jpeds.2016.05.011.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Conclusion—Low maternal Hb concentration during 24-28 weeks of gestation was associated 
with an increased risk of anemia in infancy, whereas high maternal Hb concentration was 
associated with a reduced risk of anemia.
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According to recent studies, 30-50% infants aged 6 months in the developing countries 
suffer from anemia1-3. Infant anemia can lead to lack of oxygen in organs and tissues, thus 
increasing the risk of infectious diseases4, mortality, and other morbidities5, 6 including 
impaired cognitive7, 8 and physical development9 which may be irreversible, even after 
correction of anemia10, 11.
Among the many factors that affect Hb concentration during infancy, maternal Hb levels 
during gestation is considered one of the most important. Low maternal Hb concentration 
during gestation may hamper development of fetal iron stores prior to birth and therefore 
may increase the risk of anemia during infancy12. However, only a few studies have directly 
examined this relationship. In a study conducted in Jordan, anemic pregnant mothers tended 
to have infants at increased risk of developing anemia, but the sample size was very small, 
with 232 mother-infant pairs13. In contrast, a prospective study of 617 mother-infant pairs in 
Benin concluded that there was no association between maternal anemia and infant 
hemoglobin level at 18 months of age14.
In the present study, we investigated the association between maternal Hb concentration 
measured during the first trimester and again at 24-28 weeks of gestation and the risk of 
developing anemia during infancy in a population without routine iron supplementation by 
secondary analysis of data from a double-blinded randomized controlled trial conducted 
from 2006 to 2009 in northern China15.
Methods
As described elsewhere in more detail15, the primary trial was a double-blinded, randomized 
controlled study of pregnant women assigned to three treatment groups: folic acid only, folic 
acid plus iron, or multiple micronutrients containing folic acid, iron, and 13 additional 
vitamins and minerals, with perinatal mortality being the primary outcome of interest 
(ClinicalTrials.gov: NCT00133744). The subjects were women in five counties in Hebei 
Province in northern China who were nulliparous, at least 20 years of age, recorded dates of 
menstruation for at least 2 months before pregnancy, had not yet reached 20 weeks’ 
gestation, and were pregnant between May 2006 and April 2009. Eligible women were 
randomly assigned to one of the three treatment groups stratified by county and random 
block sizes (3, 6 and 9). Women whose Hb level was <100 g/L were excluded from the study 
and referred for treatment due to ethical reasons. At the time of enrollment in the trial, 
information on social, demographic, and anthropometric characteristics of the women was 
documented. During the trial, maternal Hb concentration were measured in the first trimester 
and at 24-28 weeks of gestation, and the infant Hb concentrations at 5-7 months as well as 
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11-13 months of age, with the HemoCue® B-Hemoglobin system (HemoCue AB, 
Angelholm, Sweden) according to the manufacturer's instructions.
All data were collected uniformly according to predefined criteria and entered into an 
electronic reproductive health surveillance system by trained local health care workers. The 
project was approved by the institutional review board of Peking University, Beijing, China, 
and renewed annually. Verbal informed consent was obtained from all subjects.
According to the recommendation proposed by the WHO, both maternal and infant anemia 
were defined as Hb <110 g/L. Gestational age was calculated from the first day of the 
mother's last menstrual period. Infant age was calculated from the date of birth.
Eighteen thousand, seven hundred seventy-five women completed the original trial. During 
the follow-up period, 61 women were lost to follow-up, 2 died, 815 had abortions, and there 
were 67 multiple pregnancies and 82 stillbirths, leaving 17748 singleton livebirths. For the 
present analysis, we further excluded 555 subjects due to incomplete data, as a result, the 
final sample size included 17,193 mother-infant pairs (Figure 1).
Statistical analyses
Pearson correlation was used to examine the linear relationship between maternal Hb 
concentration and infant Hb concentration. Unconditional logistics regression was used to 
examine maternal Hb level (independent variable) as a risk or protective factor for infant 
anemia (dependent variable), with adjustment for potential confounding factors including 
education and preterm birth. Hb concentrations were categorized into 4 levels in 10-g/L 
intervals, with 110-119 g/L being used as the referent. Adjusted odds ratios (AORs) for each 
Hb level relative to the referent and their 95% confidence intervals (CIs) were calculated 
from the logistic model. All tests were two-sided, and a P value less than 0.05 was 
considered statistically significant. Data were analyzed with SPSS software (v. 11.5; SPSS, 
Chicago, IL, USA).
Results
Subjects were enrolled between May 2006 and April 2009. Maternal social, demographic, 
and anthropometric characteristics are presented in Table I. The participants were 
predominantly young women (mean age: about 23 years) with a relatively low level of 
education (almost 80% had completed a secondary education). Almost all participants (99%) 
were Han Chinese, and more than 90% of the women were farmers. The rate of preterm 
birth was 5.4%.
Mean age for the first infant Hb measurement was 6.3 ± 0.4 months, and 12.3 ± 0.4 months 
for the second measurement. Mean infant Hb concentration was 121.7 g/L at 5-7 months and 
122.1 g/L at 11-13 months of age. With increasing age in this population, the prevalence of 
anemia decreased: 6.7% infants were anemic at 5-7 months, while 5.3% were anemic at 
11-13 months of age.
There was no correlation between maternal Hb concentration in the first trimester and infant 
Hb concentration at 5-7 months or 11-13 months. In contrast, maternal Hb levels during 
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24-28 weeks of gestation were significantly correlated with infant Hb concentrations at both 
5-7 months and 11-13 months of age (Table II).
To further examine the association between maternal Hb concentrations during 24-28 weeks 
of gestation and the risk of infant anemia, we classified maternal Hb concentration into 4 
categories, with the Hb concentration of 110-119 g/L as reference category and adjustment 
for potential confounding factors (Table III; available at www.jpeds.com). As presented in 
Figure 2 and Table IV (Table IV available at www.jpeds.com), a maternal Hb concentration 
≤109 g/L during 24-28 weeks of gestation was associated with an increased risk of infant 
anemia at 5-7 months (AOR: 1.95, 95% CI: 1.59-2.40) as well as 11-13 months of age 
(AOR: 1.73, 95% CI: 1.36-2.18); whereas maternal Hb levels of 120-129 g/L and ≥130 g/L 
showed a protective effect on the development of infant anemia at 5-7 months of age (AOR: 
0.74, 95% CI: 0.64-0.85 for 120-129 g/L; AOR: 0.75, 95% CI: 0.63-0.90 for ≥130 g/L). A 
similar relationship was observed for infants at 11-13 months of age (AOR: 0.72, 95% CI: 
0.61-0.85 for 120-129 g/L; AOR: 0.89, 95% CI: 0.73-1.08 for ≥130 g/L), although the 
confidence intervals for the highest maternal Hb category included null (Figure 2 and Table 
V; Table V available at www.jpeds.com).
Discussion
This secondary analysis of data from a randomized controlled trial found that maternal Hb 
concentrations measured at 24-28 weeks of gestation were positively correlated with infant 
Hb concentrations at 5-7 as well as 11-13 months of age. Low maternal Hb level was a risk, 
and high maternal Hb level was a protective factor for infant anemia.
The five rural counties in which this study was conducted are located between 50 to 300 
kilometer to the east or south-west of Beijing, with an average altitude lower than 50 meters. 
The socioeconomic development level is medium or medium-high compared with other 
northern rural counties. The population is homogeneous, with a vast majority being Han 
Chinese, not very mobile, and well-nourished relative to other rural populations in the north. 
The prevalence of hemoglobinopathy is estimated to range from 0.11% (the prevalence in a 
neighboring province) to 0.21% (the prevalence in Beijing)16; the rate of helminths is 
1.6%17, the rate of malaria is 0.006 per 10,00018, and HIV infection rate is 0.012% in the 
province19. There is no routine iron or multimicronutrient supplement prescription to 
pregnant women in this population.
Our findings are consistent with those previously discussed in Jordan3. In that study, 
maternal hemoglobin concentrations were measured only in the third trimester (37 weeks of 
gestation). A study from Indonesia found that maternal anemia was associated with infant 
anemia, but maternal Hb concentrations were measured at varying times postpartum, with 
the notion that maternal postpartum Hb reflects Hb during pregnancy20. Inconsistent to our 
findings, a study in Benin did not find an association between infant hemoglobin and 
maternal anemia when infants were 18 months old14.
Many factors may contribute to infant anemia. These factors could be genetic, such as 
hemoglobinopathies21; or environmental factors, including high altitude22. Other risk 
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factors, including lower birthweight20, rapid weight gain23, and male sex2 can also increase 
the likelihood of infant anemia. However, undernutrition, including iron deficiency as well 
as deficiencies of other vitamins and minerals, is considered to be the most important 
factor24. Among these nutritional deficiencies, iron deficiency is considered the most 
important single factor in the development of infant anemia25. In the studied population, 
hemoglobinopathies, malaria, helminths, and HIV infection are rare; moreover, no iron 
supplement during pregnancy is routinely prescribed. Consequently, it is believed that most 
anemia in this population is caused by iron deficiency. Poor maternal iron status contributes 
to lower iron stores in the newborn infant26. It has also been speculated that maternal iron 
deficiency in pregnancy reduces iron stores throughout the first year of life27. Our findings 
support this notion. Thus, as WHO has suggested, pregnant women should begin iron 
supplementation early during pregnancy to order to improve infant outcomes28.
The rate of infant anemia in our population is lower than that in many other developing 
countries. One of the reasons is that the population is relatively well-nourished compared 
with rural populations in other developing countries. The other reason is the exclusion at the 
time of enrollment in the original trial of those mothers with an Hb level lower than 100 g/L. 
The third reason is the variation in the definition of infant anemia used in different 
investigations.
Studies have shown that the infant anemia rate is highest around the time of the infant's 
growth spurt, especially between 6 and 24 months of age29, 30. With the infant's rapid 
growth, the blood volume is expanded, whereas the iron stores from mother have usually 
been depleted; as a result, diets become the vital source of iron. If exogenous iron is 
inadequate, infant anemia occurs. However, the amount of available iron in infant foods is 
usually low and often it cannot meet the needs of infants, which will further increase the 
likelihood of infant anemia. Our results support prior recommendations of exclusive 
breastfeeding for the first 6 months of age, with complementary foods starting at age of 6 
months and breastfeeding continuing until 2 years of age2. Also, as suggested by WHO, 
food fortified with iron and other micronutrients may help reduce the risk of anemia, 
especially for infants in their first year of life31.
Our study has several strengths. All data were collected prospectively; this helps reduce the 
recall bias that is common in cross-sectional or case-control studies. Second, Hb 
measurements for mothers and infant were standardized, thus minimizing the potential 
problems associated with routine measurement of Hb levels in clinical settings. In addition, 
women had their menstrual period recorded 2 months before enrollment, which can ensure a 
more accurate ascertainment of gestational age. Third, this population has a very low 
incidence of other major factors for anemia, such as HIV infection, parasite infection, 
hemoglobinopathy, and malnutrition, thus minimizing the possibility that these factors 
confounded the observed associations. Finally, our sample size is big enough for detailed 
analysis.
Our findings should be interpreted cautiously because at the time of enrollment of the 
original trial, women with an Hb level below 100 g/L were excluded; this may have 
weakened the finding of a relationship between low Hb concentration and infant 
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anemia32, 33. Another limitation is that we did not have information on infant feeding 
practices. However, there is no evidence to show that mothers with low Hb concentrations 
during pregnancy tend to have feeding practices that differ from mothers with normal Hb 
and that might predispose infants to anemia. This means that the observed associations are 
less likely to be confounded by feeding practices. Finally, genetic factors, such as inheriting 
a hemoglobinopathy trait from the mother might have affected the results. However, since 
hemoglobinopathies are rare in this population, these inheritable diseases should not have 
had a meaningful impact on the associations we observed in this study.
In conclusion, maternal Hb concentration at 24-28 weeks of gestation was correlated with 
infant Hb concentrations at 5-7 months as well as 11-13 months of age. Low maternal Hb 
levels during pregnancy were associated with an increased risk of infant anemia and high 
maternal Hb level were associated with a reduced risk of infant anemia. Further studies are 
warranted to reveal the mechanism underlying these associations.
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Figure 1. 
Flowchart of participants
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Figure 2. 
Risk (odds ratio) of infant anemia during A, 5-7 months and B, during 11-13 months by 
maternal hemoglobin level of 24-28 weeks of gestation in a Chinese population, 2006-2009. 
A, AOR (95% CI) for Maternal Hb concentration ≤109 is 1.95 (1.59-2.40); 0.74 (0.64-0.85) 
for 120-129 g/L; 0.75 (0.63-0.90) for ≥130 g/L. B, AOR (95% CI) for Maternal Hb 
concentration ≤109 is 1.72 (1.36-2.18); 0.72 (0.61-0.85) for 120-129 g/L; 0.89 (0.73-1.08) 
for ≥130 g/L.
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TABLE 1
Characteristics of the study subjects in northern rural China, 2006-2009
Characteristics x̄ or n SD or %
Maternal age (year) 23.6 2.8
Mean BMI 22.1 2.9
Mean gestational weeks at enrollment 12.1 4.6
Ethnic group
    Han 1,6988 98.8
    Other 205 1.2
Education
    High school or above 3113 18.1
    Secondary 1,3806 80.3
    Primary or less 274 1.6
Occupation
    Farmer 1,5644 91.0
    Other 1549 9.0
Group
    Folic acid 5737 33.4
    Iron/folic acid 5750 33.4
    Multiple micronutrients containing iron and folic acid 5706 33.2
Preterm birth 933 5.4
Child sex
    Male 9022 52.5
    Female 8171 47.5
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TABLE 3
Maternal and infant characteristics and the risk (odds ratio) of infant anemia in a rural population in northern 
China, 2006-2009
Characteristics Infant anemia during 5-7 months Infant anemia during 11-13 months
P OR (95% CI) P OR (95% CI)
Maternal age (year) 0.118 0.98 (0.96-1.00) 0.220 0.99 (0.96-1.01)
BMI 0.050 1.02 (1.00-1.04) 0.990 1.00 (0.98-1.02)
Gestational weeks at enrollment 0.885 1.00 (0.99-1.01) 0.995 1.00 (0.99-1.02)
Ethnic group 0.608 0.944
    Han 1.17 (0.65-2.10) 0.98 (0.53-1.80)
    Other 1.00 1.00
Education 0.001 <0.001
    High school or above 0.48 (0.32-0.71) 0.35 (0.23-0.53)
    Secondary 0.55 (0.38-0.81) 0.44 (0.30-0.65)
    Primary or less 1.00 1.00
Occupation 0.100 0.770
    Farmer 0.85 (0.70-1.03) 1.04 (0.82-1.31)
    Other 1.00 1.00
Group 0.904 0.152
    Folic acid 1.03 (0.89-1.19) 0.92 (0.78-1.08)
    Iron/folic acid 1.00 (0.86-1.16) 0.85 (0.72-1.00)
    Multiple micronutrients 1.00 1.00
Child Sex 0.614 0.255
    Male 1.03 (0.92-1.16) 1.08 (0.95-1.24)
    Female 1.00 1.00
Preterm birth 0.044 0.231
    No 0.78 (0.62-0.99) 0.85 (0.64-1.11)
    Yes 1.00 1.00
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